New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 23, 2014
04:55 EDTMBLTY, MBLTY, MBLTY, AZN, AZN, AZN, PFE, PFE, PFE, JNJ, JNJ, JNJ, MRK, MRK, MRK, NBS, NBS, NBS, XOMA, XOMA, XOMA, NVO, NVO, NVO, SNY, SNY, SNY, LLY, LLY, LLYGlobal Technology Community to hold a summit
7th Annual Diabetes Summit is being held in Cambridge, MA on April 23-25.
News For MBLTY;SNY;NVO;XOMA;NBS;MRK;JNJ;PFE;AZN;LLY From The Last 14 Days
Check below for free stories on MBLTY;SNY;NVO;XOMA;NBS;MRK;JNJ;PFE;AZN;LLY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
August 12, 2014
08:52 EDTSNYSanofi launches authorized generic version of Eloxatin through Winthrop US
Subscribe for More Information
05:58 EDTAZNStocks with implied volatility movement; P AZN
Subscribe for More Information
August 11, 2014
15:51 EDTSNYMannKind price target raised to $10 from $6.50 at Piper Jaffray
Subscribe for More Information
11:58 EDTSNY, LLY, NVOMannKind rallies after inking licensing agreement with Sanofi
Subscribe for More Information
09:06 EDTSNYOn The Fly: Pre-market Movers
HIGHER: PharmAthene (PIP), up 55% after announcing that a Delaware court awarded the company lump sum expectation damages for the value of its lost profits for SIGA Technologies' (SIGA) smallpox antiviral, Tecovirimat... MannKind (MNKD), up 19% after entering exclusive licensing agreement for development and commercialization of Afrezza inhaled insulin with Sanofi (SNY)... Kinder Morgan (KMI), up 19% after announcing it will acquire all of the outstanding equity securities of Kinder Morgan Energy Partners (KMP), Kinder Morgan Management (KMR) and El Paso Pipeline Partners (EPB)... Tesla (TSLA), up 2.7% following upgrade at Deutsche Bank... Achillion (ACHN), up 6% following upgrades at Wells Fargo and at Piper Jaffray... PepsiCo (PEP), up 0.9% following upgrade at UBS. LOWER: Dean Foods (DF), down 8.6% after reporting Q2 losses that were steeper than expected, saying balance of year "appears rocky," which makes it difficult to provide guidance beyond the immediate quarter... Priceline (PCLN), down 0.7% after reporting Q2 revenue that missed expectations, guiding Q3 EPS below consensus... SIGA Technologies, down 31% after ruling in suit with PharmAthene... 2U (TWOU), down 4.3% after downgraded at Goldman.
07:45 EDTSNYMannKind partnership likely to be viewed favorably, says Piper Jaffray
Subscribe for More Information
07:07 EDTSNYIgnyta names Adrian Senderowicz as Chief Medical Officer
Ignyta (RXDX) announced that Adrian Senderowicz, M.D., has been appointed as Chief Medical Officer and SVP, Clinical Development and Regulatory Affairs. Senderowicz was most recently Vice President, Global Regulatory Oncology at Sanofi (SNY).
06:31 EDTSNYMannKind to host conference call
Conference call to discuss the collaboration with Sanofi about global licensing agreement for development and commercialization of Afrezza will be held on August 11 at 8:30 am. Webcast Link
05:13 EDTSNYSanofi, MannKind announce global licensing agreement for Afrezza
Subscribe for More Information
August 8, 2014
10:16 EDTXOMAHigh option volume stocks
High option volume stocks: TKMR JOE HMSY TDC XOMA XPO VGK DKS BCOR DRTX
09:16 EDTNVONovo Nordisk management to meet with JPMorgan
Subscribe for More Information
09:01 EDTJNJJohnson & Johnson remains undervalued, says Cowen
Subscribe for More Information
06:39 EDTPFEPfizer faces torrent of Lipitor suits, Reuters says
Subscribe for More Information
August 7, 2014
16:57 EDTNBSNeoStem reports Q2 revenue $4.5M, consensus $4.75M
Reports Q2 net loss ($12.8M) compared with ($8.6M) for the three months ended June 30, 2013. EPS consensus (30c). At June 30, NeoStem's cash and cash equivalents, and marketable securities totaled $33.8M.
16:17 EDTXOMAXOMA backs view of $55M-$60M cash used in ongoing ops in 2014
Subscribe for More Information
16:16 EDTXOMAXOMA reports Q2 EPS with gain (17c), consensus (21c)
Subscribe for More Information
08:40 EDTSNYSanofi and Immune Design enters licensing agreement for use of GLASStm
Subscribe for More Information
08:12 EDTPFEPfizer says EMA accpets application seeking new indication for Prevenar 13
Subscribe for More Information
07:42 EDTSNYPOZEN plans to make future employee reductions
Subscribe for More Information
06:13 EDTAZNDynavax says AZD1419 Phase 1 study met secondary endpoints
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use